Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome
Abstract Neurodegenerative disorders are accompanied by neuronal degeneration and glial dysfunction, resulting in cognitive, psychomotor, and behavioral impairment. Multiple factors including genetic, environmental, metabolic, and oxidant overload contribute to disease progression. Recent evidences...
Main Authors: | Archana Arjunan, Dhiraj Kumar Sah, Minna Woo, Juhyun Song |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-023-00966-z |
Similar Items
-
A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression
by: Martina Chrudinová, et al.
Published: (2024-02-01) -
Identification of IGF-1 Effects on White Adipose Tissue and Hippocampus in Alzheimer’s Disease Mice via Transcriptomic and Cellular Analysis
by: Young-Kook Kim, et al.
Published: (2024-02-01) -
The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer
by: Haim Werner, et al.
Published: (2021-04-01) -
Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
by: Julian Bailes, et al.
Published: (2021-02-01) -
Association between Expression of Insulin-like Growth Factor-1 (IGF-1), IGF-1 Receptor (IGF-1R), and Hypertension-Mediated Organ Damage (HMOD) Parameters in Leukocytes and Plasma of Children/Adolescents with Primary Hypertension
by: Renata Grzywa-Czuba, et al.
Published: (2024-02-01)